share_log

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga ·  Nov 9 05:06

Gainers

  • Tivic Health Systems (NASDAQ:TIVC) shares increased by 75.3% to $0.46 during Friday's pre-market session. The company's market cap stands at $2.8 million.
  • Doximity (NYSE:DOCS) stock rose 29.94% to $56.42. The company's market cap stands at $10.4 billion. As per the press release, Q2 earnings came out yesterday.
  • Fortrea Holdings (NASDAQ:FTRE) stock rose 26.31% to $22.8. The market value of their outstanding shares is at $2.0 billion. As per the news, the Q3 earnings report came out today.
  • Tenaya Therapeutics (NASDAQ:TNYA) shares moved upwards by 20.39% to $3.01. The company's market cap stands at $237.4 million. The company's, Q3 earnings came out 2 days ago.
  • Indaptus Therapeutics (NASDAQ:INDP) stock rose 15.11% to $1.37. The company's market cap stands at $13.9 million.
  • CytomX Therapeutics (NASDAQ:CTMX) shares rose 14.99% to $1.15. The company's market cap stands at $89.8 million. As per the news, the Q3 earnings report came out yesterday.

Losers

  • ProPhase Labs (NASDAQ:PRPH) stock declined by 51.8% to $0.69 during Friday's pre-market session. The company's market cap stands at $13.1 million.
  • Maravai LifeSciences (NASDAQ:MRVI) stock decreased by 40.06% to $4.7. The market value of their outstanding shares is at $665.3 million. As per the news, the Q3 earnings report came out yesterday.
  • Evolent Health (NYSE:EVH) stock decreased by 38.75% to $15.05. The market value of their outstanding shares is at $1.7 billion. As per the press release, Q3 earnings came out yesterday.
  • Agilon Health (NYSE:AGL) stock fell 33.34% to $1.86. The market value of their outstanding shares is at $765.3 million. As per the news, the Q3 earnings report came out yesterday.
  • AlloVir (NASDAQ:ALVR) shares declined by 29.7% to $0.69. The market value of their outstanding shares is at $79.6 million.
  • Revance Therapeutics (NASDAQ:RVNC) shares decreased by 25.61% to $4.3. The company's market cap stands at $447.9 million. The company's, Q3 earnings came out yesterday.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment